Lori Lawley
2023
In 2023, Lori Lawley earned a total compensation of $569.8K as Chief Financial Officer at NewLink Genetics, a 18% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $109,480 |
|---|---|
| Option Awards | $28,026 |
| Salary | $391,000 |
| Stock Awards | $3,520 |
| Other | $37,749 |
| Total | $569,775 |
Lawley received $391K in salary, accounting for 69% of the total pay in 2023.
Lawley also received $109.5K in non-equity incentive plan, $28K in option awards, $3.5K in stock awards and $37.7K in other compensation.
Rankings
In 2023, Lori Lawley's compensation ranked 1,615th out of 2,338 executives tracked by ExecPay. In other words, Lawley earned more than 30.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,615 out of 2,338 | 31st |
Division Manufacturing | 915 out of 1,259 | 27th |
Major group Chemicals And Allied Products | 569 out of 711 | 20th |
Industry group Drugs | 554 out of 682 | 19th |
Industry Pharmaceutical Preparations | 397 out of 493 | 20th |
Source: SEC filing on April 12, 2024.
Lawley's colleagues
We found two more compensation records of executives who worked with Lori Lawley at NewLink Genetics in 2023.
News
NewLink Genetics CEO Richard Hawkins' 2023 pay falls 25% to $953K
April 12, 2024
NewLink Genetics CEO Richard Hawkins' 2022 pay slips 6% to $1.3M
March 31, 2023
NewLink Genetics CSO John McKew's 2021 pay rises 15% to $1.4M
March 23, 2022
NewLink Genetics CEO Richard Hawkins' 2020 pay jumps 200% to $2.2M
April 6, 2021